These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9434469)

  • 41. Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
    Yasuda H; Hirai A; Joko M; Terada M; Kawabata T; Maeda K; Haneda M; Kashiwagi A; Maeda T; Kikkawa R
    Diabetes Care; 2000 May; 23(5):705. PubMed ID: 10834436
    [No Abstract]   [Full Text] [Related]  

  • 42. [Aldose reductase inhibitor].
    Hotta N
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():147-54. PubMed ID: 21667476
    [No Abstract]   [Full Text] [Related]  

  • 43. [SG-210].
    Akira T; Naka H
    Nihon Rinsho; 1997 Nov; 55 Suppl():216-20. PubMed ID: 9434470
    [No Abstract]   [Full Text] [Related]  

  • 44. [Epalrestat].
    Hotta N
    Nihon Rinsho; 1997 Nov; 55 Suppl():204-11. PubMed ID: 9434468
    [No Abstract]   [Full Text] [Related]  

  • 45. A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes.
    Eaton RP; Sibbitt WL; Shah VO; Dorin RI; Zager PG; Bicknell JM
    J Diabetes Complications; 1998; 12(1):34-8. PubMed ID: 9442813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aldose reductase inhibitors: recent developments.
    Sarges R; Oates PJ
    Prog Drug Res; 1993; 40():99-161. PubMed ID: 8356214
    [No Abstract]   [Full Text] [Related]  

  • 47. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.
    Fagius J; Brattberg A; Jameson S; Berne C
    Diabetologia; 1985 Jun; 28(6):323-9. PubMed ID: 3930330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of long-term aldose reductase inhibitor therapy on autonomic dysfunction of urinary bladder, stomach and cardiovascular systems in diabetic patients.
    Green A; Jaspan J; Kavin H; Chung S; Schoenberg H
    Diabetes Res Clin Pract; 1987 Nov; 4(1):67-75. PubMed ID: 3121273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathology of diabetic neuropathy and the effects of aldose reductase inhibitors.
    Gillon KR; King RH; Thomas PK
    Clin Endocrinol Metab; 1986 Nov; 15(4):837-53. PubMed ID: 3096616
    [No Abstract]   [Full Text] [Related]  

  • 51. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.
    Young RJ; Ewing DJ; Clarke BF
    Diabetes; 1983 Oct; 32(10):938-42. PubMed ID: 6225686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro.
    Kawamura T; Suzuki K; Matsumae H; Sano T; Sakamoto N; Hotta N
    Diabet Med; 1995 May; 12(5):392-6. PubMed ID: 7648800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus.
    Bareford D; Jennings PE; Stone PC; Baar S; Barnett AH; Stuart J
    J Clin Pathol; 1986 Jul; 39(7):722-7. PubMed ID: 3090107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vascular endothelial function].
    Naruse K
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():568-72. PubMed ID: 21667513
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical potential of aldose reductase inhibitors in diabetic neuropathy.
    Hamada Y; Nakamura J
    Treat Endocrinol; 2004; 3(4):245-55. PubMed ID: 16026107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus.
    Robey C; Dasmahapatra A; Cohen MP; Suarez S
    Diabetes; 1987 Sep; 36(9):1010-3. PubMed ID: 3609495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fidarestat. Aldos, SK 860, SNK 860.
    Drugs R D; 2002; 3(4):232-4. PubMed ID: 12455198
    [No Abstract]   [Full Text] [Related]  

  • 58. Diabetic neuropathy in the upper limb and the effect of twelve months sorbinil treatment.
    Guy RJ; Gilbey SG; Sheehy M; Asselman P; Watkins PJ
    Diabetologia; 1988 Apr; 31(4):214-20. PubMed ID: 3290018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Role of aldose reductase in the progression of diabetic retinopathies].
    Akagi Y; Kubo E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():194-201. PubMed ID: 15999706
    [No Abstract]   [Full Text] [Related]  

  • 60. [Medical treatment of diabetic neuropathy].
    Hamada Y
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():254-9. PubMed ID: 27266098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.